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decreased paw withdrawal threshold. These findings sug-
gest that LEAA supplementation improves the rate of mus-
cle protein synthesis and ameliorates muscle soreness after 
eccentric exercise.
Keywords Eccentric contractions · Muscle protein 
synthesis · Muscle soreness · Leucine-enriched essential 
amino acids · mTOR
Introduction
The importance of muscle mass, strength, and metabolic 
function in athletic performance, daily activities, and 
general health is widely recognized. Resistance exercise 
increases muscle size and strength. The effect of resistance 
exercise on skeletal muscle growth depends on the mode 
of contraction and duration, intensity, and frequency of 
exercise (Tesch 1988). Several studies have compared the 
effects of resistance exercise with concentric and/or eccen-
tric contractions (ECs), showing that eccentric exercise 
results in greater gains in muscle strength and size than 
concentric exercise because of greater overload induced 
by ECs (Higbie et al. 1996). Therefore, eccentric exer-
cise is considered important for exercise-induced muscle 
hypertrophy.
However, eccentric exercise-biased training is not widely 
used, partly because eccentric exercise has some adverse 
effects. Eccentric exercise results in prolonged muscle weak-
ness and muscle soreness (Proske and Morgan 2001), which 
are symptoms of muscle damage. This muscle soreness gradu-
ally develops and lasts for several days (Nosaka 2007). Mus-
cle soreness and muscle weakness reduce the ability to per-
form athletic activities and potentially prevent regular exercise 
(Cleak and Eston 1992). Therefore, to make eccentric exercise 
Abstract Eccentric exercise results in prolonged muscle 
weakness and muscle soreness, which are typical symp-
toms of muscle damage. Recovery from muscle dam-
age is related to mammalian target of rapamycin (mTOR) 
activity. Leucine-enriched essential amino acids (LEAAs) 
stimulate muscle protein synthesis via activation of the 
mTOR pathway. Therefore, we investigated the effect of 
LEAAs on muscle protein synthesis and muscle soreness 
after eccentric contractions (EC). Male Sprague–Dawley 
rats (9–11 weeks old) were administered an LEAA solu-
tion (AminoL40; containing 40 % leucine and 60 % other 
essential amino acids) at 1 g/kg body weight or distilled 
water (control) 30 min before and 10 min after EC. Tibialis 
anterior (TA) muscle was exposed to 500 EC by electrical 
stimulation under anesthesia. The fractional synthesis rate 
(FSR; %/h) in the TA muscle was measured by incorporat-
ing l-[ring-2H5] phenylalanine into skeletal muscle protein. 
Muscle soreness was evaluated by the paw withdrawal 
threshold using the Randal–Selitto test with some modi-
fications from 1 to 3 days after EC. The FSR in the EC-
control group (0.147 ± 0.016 %/h) was significantly lower 
than in the sedentary group (0.188 ± 0.016 %/h, p < 0.05). 
AminoL40 administration significantly mitigated the EC-
induced impairment of the FSR (0.172 ± 0.018 %/h). EC 
decreased the paw withdrawal threshold at 1 and 2 days 
after EC, which indicated that EC induced muscle sore-
ness. Furthermore, AminoL40 administration alleviated the 
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possible for various practical uses, (e.g., promoting general 
health and athletic performance), an effective intervention 
that decreases the adverse effects, and augments the positive 
effects of the eccentric exercise, needs to be identified.
The initial phase of the recovery process from muscle 
damage is characterized by inflammation and degenera-
tion of damaged tissue. Satellite cells are then activated, 
and they proliferate, differentiate, and fuse to myofibrils 
to repair muscle tissue (Charge and Rudnicki 2004). The 
recovery process is regulated by intracellular signaling 
pathways that control protein turnover, maintaining a bal-
ance between muscle protein synthesis and muscle protein 
degradation. Among these pathways, the mammalian tar-
get of rapamycin (mTOR) pathway is an essential step for 
muscle regeneration (Ge et al. 2009).
Amino acids are known to be an important nutrient for 
stimulation of muscle protein synthesis. Resistance exercise 
and feeding of amino acids have a marked stimulatory effect 
on the rate of muscle protein synthesis (Biolo et al. 1997). 
Among amino acids, essential amino acids play an impor-
tant role in increasing the rate of muscle protein synthesis 
(Volpi et al. 2003). Among essential amino acids, leucine in 
particular plays a specific role in stimulation of the mTOR 
pathway (Crozier et al. 2005). However, administration of 
leucine alone or a branched chain amino acids (BCAAs) 
mixture leads to a decrease in plasma concentrations of other 
essential amino acids in neonatal pigs (Escobar et al. 2005) 
and in humans (Borgenvik et al. 2012). In normal swine, 
reduced availability of amino acids leads to reduced muscle 
protein synthesis and amino acid supplementation reverses 
this effect (Kobayashi et al. 2003). Furthermore, insulin-
mediated hypoaminoacidemia reduces protein synthesis; this 
is mitigated by increased availability of all amino acids, but 
not leucine alone. Therefore, essential amino acids, other 
than BCAAs and leucine may be essential for sustaining 
muscle protein synthesis. Accordingly, leucine-enriched 
essential amino acids (LEAAs) increase the rate of muscle 
protein synthesis after several types of exercise (Dreyer et al. 
2008; Pasiakos et al. 2011). However, there are no reports on 
the effect of LEAAs on recovery from muscle soreness after 
eccentric exercise. Some reports have shown that administra-
tion of amino acids (Nosaka et al. 2006), particularly leucine 
(Kirby et al. 2012) or BCAAs (Jackman et al. 2010), admin-
istration suppresses delayed-onset muscle soreness (DOMS) 
1 day after exercise in humans. However, the mechanism by 
which amino acids act to decrease the degree of muscle sore-
ness, and the optimal composition of amino acids to reduce 
the muscle soreness, remain unclear.
Wide individual variability of muscle soreness after 
eccentric exercise have been reported (Gulbin and Gaffney 
2002), and this creates a problem in assessing the effects 
of prophylactic or therapeutic interventions on muscle sore-
ness. The wide individual variability is not attributed to 
genetic variability, and may be attributed to the precondi-
tioning induced by daily muscle contractile activity (Gulbin 
and Gaffney 2002). Thus, in order to investigate the opti-
mal composition of amino acid to decrease muscle soreness 
or the mechanism by which amino acids acts to decrease 
muscle soreness, the animal model in which muscle con-
tractile activity can be properly controlled, is required.
The purpose of this study was to investigate: (1) the 
effect of LEAAs on muscle soreness, which is a typical 
symptom of exercise-induced muscle damage, and (2) the 
effect of LEAAs on the rate of muscle protein synthesis 
after ECs in rats. The tibialis anterior (TA) muscle of rats 
was forced to contract by electrical stimulation. The frac-
tional synthesis rate (FSR; %/h) was determined by calcu-
lating the incorporation rate of L-[ring-2H5] phenylalanine 
into the skeletal mixed muscle protein pool. Muscle sore-
ness was evaluated by measuring the mechanical paw with-
drawal threshold according to the pressure stimulus.
Materials and methods
Animals
This study was approved by the Institutional Animal Care 
and Use Committee of Ajinomoto Co., Inc. Male Sprague–
Dawley rats (300–350 g; Charles River Laboratories Japan, 
Inc., Yokohama, Japan) were used in this study. The rats 
were housed in a temperature-controlled room on a 12-h 
light–dark cycle. They were also provided a standard com-
mercial chow (CR-F1; Charles River Laboratories Japan, 
Inc., Yokohama, Japan) and water was provided ad libitum 
throughout the experiment.
Experimental design
Experiment 1 The effect of LEAAs on the FSR in the TA 
muscle after ECs was investigated in rats after 3 h of food 
deprivation. The rats were divided into one of three groups: 
Sed, sedentary controls and administration of distilled 
water as a control (n = 9); EC-Con, ECs and administra-
tion of distilled water as a control (n = 10); EC-AminoL40, 
ECs and administration of LEAAs (n = 9). The TA muscle 
was stimulated electrically via needle electrodes that were 
inserted near the common peroneal nerve under anesthesia 
with sodium pentobarbital (50 mg/kg, i.p.). Electrical stim-
ulation was applied for 1 s with current strength, which is 
three times as much as the twitch threshold (<100 μA), and 
a frequency of 50 Hz with a pulse duration of 1 ms was 
used (Taguchi et al. 2005). The TA muscle was simultane-
ously stretched with electrical stimulation from an ankle 
position of 45° to 135° over a 1-s period with the use of 
a linearized servomotor (CPL28T2B-06KD, OrientalMotor 
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Co. Ltd, Tokyo, Japan), and then returned to the starting 
position over 3 s (ankle position was defined as the angle 
between the tibia and the plantar surface of the foot, with 
180° representing a completely extended foot). The elec-
trical stimulation was repeated every 4 s for a total of 
500 repetitions. EC-AminoL40 group was administered 
LEAAs (1 g/kg body weight) by oral gavage 30 min before 
and 10 min after EC because of following. (1) It has been 
reported that some types of amino acid supplementation 
(e.g., leucine alone, BCAAs or a 12 amino acids mix-
ture) before and immediately after exercise may attenuate 
muscle soreness (Jackman et al. 2010; Kirby et al. 2012; 
Nosaka et al. 2006). (2) It has been reported that plasma 
amino acid concentrations reached a level sufficient to 
stimulate the mTOR pathway 30 min after ingestion of a 
0.3375 or 0.675 g/kg leucine (Crozier et al. 2005). (3) After 
EC, we administered the amino acids as soon as the rats 
awoke from anesthesia, which took 10 min. The AminoL40 
mixture consisted of essential amino acids in the follow-
ing proportions: histidine, 2 %; isoleucine, 11 %; leucine, 
40 %; lysine, 17 %; methionine, 3 %; phenylalanine, 7 %; 
threonine, 9 %; tryptophan, 1 %; and valine, 11 % (Except 
for the higher proportion of leucine, this mixture contains 
the ratio of essential amino acids found in whey protein; 
all amino acids were manufactured by Ajinomoto Co., Inc., 
Tokyo, Japan). The AminoL40 mixture was developed with 
the specific purpose of avoiding substantially decreasing 
the availability of the other EAAs while increasing the pro-
portion of leucine. Both the Sed and EC-Con groups were 
administrated distilled water as a control. The FSR was 
evaluated using the flooding dose method as described by 
Garlick and McNurlan (1998). Briefly, 30 min after sec-
ond oral administration, rats in all groups were injected 
with flooding doses of phenylalanine (1.5 mmol/kg body 
weight) containing l-[ring-2H5]-phenylalanine (50 MPE, 
Cambridge isotope, Cambridge, MA) iv into the tail vein. 
20 min after the phenylalanine injection, blood was col-
lected from the abdominal aorta, the TA muscle was then 
removed under anesthesia, and frozen in liquid nitrogen 
and stored at −80 °C. Blood was separated from plasma 
by centrifugation at 10,000×g for 10 min at 4 °C, and the 
plasma was stored at −80 °C.
Experiment 2 EC and administration of LEAAs or dis-
tilled water were applied under the same conditions as 
experiment 1 (EC-Con and EC-AminoL40 groups, n = 11 
per group). Muscle soreness was evaluated by mechanical 
paw withdrawal threshold as previously described (Tagu-
chi et al. 2005). Briefly, a Randall–Selitto analgesiometer 
(Ugo Basile, Italy) equipped with a probe with a tip diam-
eter of 2.6 mm was used to measure mechanical paw with-
drawal threshold. The TA muscle was pushed by the probe 
through shaved skin. The speed of force increment was set 
at 157 mN/s. The intensity of pressure causing an escape 
reaction was defined as the mechanical paw withdrawal 
threshold. The mechanical paw withdrawal threshold was 
evaluated before, and 1, 2, and 3 days after EC.
Measurement of the FSR
Approximately 30 mg of TA muscle was homogenized in 
15 % sulfosalicylic acid, and the homogenate was centri-
fuged at 10,000×g for 10 min at 4 °C. The supernatant was 
used for measurement of enrichment of free phenylalanine 
in TA muscle. The precipitate, which was hydrolyzed in 
2 ml of 6 N hydrochloric acid at 90 °C for 16 h, was used 
for measurement of enrichment of protein-bound phenyla-
lanine in TA muscle. Amino acids in the supernatant and the 
hydrolysate were purified using cation exchange chroma-
tography (Dowex 50 W 8X; Bio-Rad Laboratories, Hercu-
les, CA), and dried in a rotary evaporator (Nakajima Corp., 
Tokyo Japan). Phenylalanine enrichment (E(muscle free)) 
in the supernatant was determined by its tert-butyl 
dimethylsilyl derivatization (Thermo Fisher Scientific, 
Waltham, MA). Gas chromatography–mass spectrome-
try was used to monitor ions 336 and 341 in the electron 
impact mode (GC–MS; 6890 GC system and 5473 Network 
Mass Selective Detector, Agilent, Santa Clara, CA). Mus-
cle protein-bound phenylalanine enrichment (E(protein-bound)) 
was determined by measuring the butyl derivatization 
(HCl-n-butanol [10 v/v %]: GL Science Inc., Japan) using 
liquid chromatography–mass spectrometry to monitor 
ions 224 and 227 in the first mass spectrometry, and 122 
and 125 in the second mass spectrometry (LC–MS/MS; 
Prominence HPLC system, Shimazu, Kyoto, Japan and API 
3200, Applied Biosystems, Carlsbad, CA) using the exter-
nal standard curve approach (Calder et al. 1992).
Immunoblot analysis
Muscles were homogenized on ice in a five times volume 
of homogenization buffer [25 mM Tris–HCl (pH 7.6), 1 % 
NP-40, 0.5 % sodium deoxycholate, 0.1 % sodium dode-
cyl sulfate (SDS), 150 mM NaCl, 1 % protease inhibitor 
cocktail and 1 % phosphatase inhibitor (Sigma Aldrich, St. 
Louis, MO)]. The homogenates were separated by centrif-
ugation at 19,800×g for 30 min at 4 °C. Protein concen-
trations were assessed in duplicate using the BCA protein 
assay kit (Pierce Biotechnology, Rockford, IL). Muscle 
homogenates were solubilized in sample loading buffer 
(50 mM Tris–HCl [pH 6.8], 10 % glycerol, 6 % beta-mer-
captoethanol, 2 % SDS, and 0.1 % bromophenol blue) at a 
concentration of 7.5 mg/ml and boiled for 3 min. Samples 
were loaded on SDS–polyacrylamide gels [TGX 4–15 % 
gradient gel (Bio-Rad, Hercules, CA)]. Protein was then 
separated by electrophoresis (200 V for 40 min at room 
temperature).
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Separated proteins were transferred onto a polyvi-
nylidene fluoride membrane (no. 162-0176; Bio-Rad, 
Hercules, CA) at 200 mA in transfer buffer (25 mM Tris-
base, 192 mM glycine, and 20 % methanol). The mem-
branes were blocked for 1 h at room temperature in TBS-T 
(20 mM Tris-base, 150 mM NaCl, and 0.1 % Tween-20) 
containing 5 % bovine serum albumin (BSA), and were 
serially washed in TBS-T at room temperature. Membranes 
were then probed for specific signaling proteins using anti-
bodies for detection of p70S6K1 and phospho-p70S6K1 
(Thr 389). All antibodies were purchased from Cell Signal-
ing Technology (Beverly, MA). Membranes were incubated 
overnight at 4 °C in primary antibody buffer (5 % BSA 
in TBS-T, pH 7.6, primary antibody diluted 1:1000). The 
membranes were serially washed in TBS-T, incubated with 
horseradish peroxidase-conjugated secondary antibody 
(dilution, 1:10,000) in TBS-T for 1 h, and serially washed 
in TBS-T. Horseradish peroxidase activity was detected 
using enhanced chemiluminescence reagent (Prime West-
ern Blotting Detection System; Bio-Rad, Hercules, CA). 
Optical density measurements were obtained with densi-
tometric scanning using the LAS3000 (Fuji Film, Tokyo, 
Japan). Membranes containing phospho-detected proteins 
were stripped of primary and secondary antibodies by use 
of stripping buffer (Nacalai Tesque, Kyoto, Japan). 1 h 
after incubation in stripping buffer, membranes were rep-
robed for total protein with the specific antibody of interest. 
Immunoblot data are expressed as normalized phosphor-
protein divided by total protein (phospho/total).
Measurements of blood variables
Insulin is a powerful stimulator of protein synthesis, 
and leucine is known to stimulate insulin secretion (Cro-
zier et al. 2005). Therefore, to investigate the relation-
ship between the stimulation of the insulin secretion by 
AminoL40 and skeletal muscle protein synthesis, plasma 
insulin concentrations were measured using a commercial 
ELISA kit (Morinaga Institute Biological Science, Yoko-
hama, Japan). Plasma amino acid concentrations were 
measured with an automatic amino acid analyzer (JLC-
500; JEOL, Tokyo, Japan).
Calculations
The FSR of TA muscle protein was calculated with the 
precursor–product model. The enrichment of precur-
sor was represented by E(muscle free), and the enrichment of 
product was represented by E(protein-bound). Muscle protein 
synthesis was calculated as FSR (%/h) = E(protein-bound)/ 
(E (muscle free) × t) × 100, where t represents the time inter-
val between phenylalanine injection and tissue sampling.
Statistical analysis
Values are shown as mean ± SE. A repeated measures two-
way ANOVA followed by Bonferroni’s multiple-compari-
sons test was performed to test the mechanical withdrawal 
threshold with LEAA administration and various time 
points were the independent variables (GraphPad Prism; 
GraphPad Software Inc., San Diego, CA). Changes in the 
other measurements were examined with one-way ANOVA 
followed by Tukey’s multiple-comparisons test. Values of 
p < 0.05 were considered significant.
Fig. 1  Effect of EC and administration of AminoL40 on the FSR 
(%/h) of TA muscle protein. The FSR in TA muscle protein was sig-
nificantly lower in the EC-Con group compared with the Sed group. 
The FSR was significantly higher in the EC-AminoL40 group com-
pared with the EC-Con group. There was no significant difference in 
the FSR between the Sed and EC-AminoL40 groups. Data are shown 
as mean ± SE (n = 9 for the Sed and EC-AminoL40 groups, and 
































Fig. 2  Effect of EC and administration of AminoL40 on the rela-
tive phosphorylation state of ribosomal S6 protein kinase 1 (phos-
pho-S6K1 [Thr389]/total S6K1) in TA muscle. Phosphorylation 
of p70S6K1 was higher in the EC-Con group than the Sed group. 
Administration of AminoL40 further increased phosphorylation. Val-
ues are arbitrary units and presented as mean ± SE (n = 9 for the 
Sed and EC-AminoL40 groups, and n = 10 for the EC-Con group). 
**p < 0.01 between groups
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Results
Measurement of the FSR
The FSR in TA muscle protein was significantly lower in 
the EC-Con group compared with the Sed group (Fig. 1, 
p < 0.05). The FSR was significantly higher in the EC-
AminoL40 group compared with the EC-Con group 
(Fig. 1, p < 0.05). There was no significant difference in the 
FSR between the Sed and EC-AminoL40 groups.
Immunoblot analysis
The phosphorylation of p70S6K1 at Thr389 was signifi-
cantly higher in the EC-Con group compared with the Sed 
group (Fig. 2, p < 0.01). There was a further increase in 
phosphorylation of p70S6K1 at Thr389 in the EC-Ami-
noL40 group compared with the EC-Con group (Fig. 2, 
p < 0.01).
Blood variables
Plasma insulin levels were significantly higher in the EC-
AminoL40 group than in the EC-Con and Sed groups 
(Fig. 3, p < 0.05). Furthermore, the data points from EC-
Con and EC-AminoL40 groups have been pooled in Fig. 4; 
the data of EC-Con and EC-AminoL40 groups were 
pooled to examine the relationship between plasma insu-
lin and FSR. There was no correlation between changes 
in plasma insulin concentrations from Sed group and FSR 
(R = 0.24, p = 0.33, Fig. 4). Plasma amino acid concentra-
tions are shown in Table 1. Essential amino acid concen-
trations, except for histidine and tryptophan, were signifi-
cantly greater (2- to 10-fold greater) in the EC-AminoL40 
group compared with the Sed and EC-Con groups (Table 1, 
p < 0.05). However, histidine and tryptophan concentra-
tions were lower in the EC-AminoL40 group compared 
with the Sed and EC-Con groups, despite LEAA adminis-
tration (Table 1, p < 0.05).  
Muscle soreness
The time course of the change in the withdrawal thresh-
old after EC is shown in Fig. 5. The decrease in mechani-
cal paw withdrawal threshold to a pressure stimulus was 
significantly suppressed in the EC-AminoL40 group at 
1 and 2 days after ECs compared with the EC-Con group 

























Fig. 3  Effect of EC and administration of AminoL40 on plasma 
insulin concentrations. Insulin concentrations did not differ between 
the Sed and EC-Con groups, but were significantly higher in the EC-
AminoL40 group compared with both the Sed and EC-Con groups. 
Data are shown as mean ± SE (n = 9 for the Sed and EC-AminoL40 
groups, and n = 10 for the EC-Con group) *p < 0.05 significantly dif-
ferent from other groups
Plasma Insulin concentration






Fig. 4  Correlation between the FSR in TA muscle and change in 
plasma insulin concentrations from Sed group. The 19 data points 
from EC-Con and EC-AminoL40 have been pooled in this figure. 
There was no significant correlation between the FSR in TA muscle 
and change in plasma insulin concentrations (R = 0.24, p = 0.33)
Table 1  Plasma amino acid concentrations
Amino acid concentrations (μM) in plasma were measured 50 min 
following the second administration of distilled water or AminoL40. 
Values are mean ± SE (n = 9 for the Sed and EC-AminoL40 groups, 
and n = 10 for the EC-Con group)
* p < 0.05 significantly different from the EC-Con group
+
 p < 0.05 significantly different from the Sed group
Sed EC-Con Ec-Amino L40
Histidine 105.1 ± 5.0 110.0 ± 5.4 97.0 ± 6.5*, +
Isoleucine 106.8 ± 6.7 99.1 ± 6.0 409.3 ± 42.7*, +
Leucine 177.1 ± 10.5 160.9 ± 10.0 1652.8 ± 157.2*, +
Lysine 522.3 ± 33.2 474.6 ± 21.6 1240.7 ± 102.9*, +
Methionine 83.2 ± 5.4 82.4 ± 5.6 161.9 ± 12.0*, +
Phenylalanine 1337.0 ± 67.4 1327.5 ± 92.4 1368.3 ± 95.9
Threonine 487.5 ± 32.1 488.7 ± 35.1 1051.5 ± 101.7*, +
Tryptophan 138.4 ± 11.6 107.8 ± 6.6 101.6 ± 8.4+
Valine 268.4 ± 16.9 250.8 ± 14.8 891.7 ± 69.8*, +
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Discussion
The objective of this study was to investigate the effect of 
LEAAs on the rate of muscle protein synthesis and mus-
cle soreness after eccentric exercise in rats. First, through 
the comparison of the EC-Con the Sed groups (which 
both received distilled water) we observed that the muscle 
protein synthesis was blunted 60 min after EC. Second, 
through the comparison between EC-AminoL40 and EC-
Con groups, we found that administration of LEAAs sig-
nificantly alleviated the EC-induced impairment of muscle 
protein synthesis, and induced greater phosphorylation of 
p70S6K1 than EC alone. Furthermore, LEAA reduced the 
muscle soreness evidenced by the decrease in the mechani-
cal paw withdrawal threshold 1 and 2 days after EC. The 
current results suggested that LEAA administration could 
alleviate the impaired muscle protein synthesis and muscle 
soreness induced by eccentric exercise.
We found that EC decreased muscle protein synthesis. 
Skeletal muscle protein synthesis is blunted 1 h after pro-
longed exercise in rodents (Anthony et al. 1999). However, 
exercise is associated with maintenance or hypertrophy of 
skeletal muscle and not atrophy. Therefore, the rate of mus-
cle protein synthesis must increase during recovery from 
exercise. In humans, a previous study showed that skel-
etal muscle protein synthesis is blunted during resistance 
exercise. The same study also reported that an increase 
in AMP-activated protein kinase (AMPK) activity and a 
reduced phosphorylation of 4E-BP1 may contribute to the 
suppression of skeletal muscle protein synthesis. (Dreyer 
et al. 2006). It has been generally accepted that mTOR con-
trols both 4E-BP1 and p70S6K1 directly. However, mTOR 
phosphorylation was unchanged immediately after exercise 
during the time when 4E-BP1 phosphorylation was reduced 
in Dreyer’s study (Dreyer et al. 2006). Furthermore, dur-
ing post-exercise recovery, when muscle protein synthesis 
was stimulated, the increase in mTOR phosphorylation was 
associated with an increase in p70S6K1 phosphorylation. 
It suggested that the signaling mechanisms of mTOR to 
4E-BP1 and p70S6K1 are regulated differentially and may 
be associated with the other mechanisms such as upstream 
regulation by TCS2 (Inoki et al. 2003). In the current study, 
60 min after EC the phosphorylation of p70S6K1 was five 
times higher in the EC-Con than in the Sed group. How-
ever, skeletal muscle protein synthesis remained blunted. 
It indicated that AMPK activation or the other mechanisms 
which suppress the skeletal muscle protein synthesis still 
remained to be clear.
Notably, LEAA administration further increased the 
phosphorylation of p70S6K1 relatively to that induced by 
EC alone. Although we did not measure any other signal-
ing molecules related to an mTOR pathway, the dose of 
leucine administered in our study (0.4 g/kg body weight 
twice, with a total dose of 0.8 g/kg body weight) has been 
previously reported to be sufficient to increase mTOR path-
way activity (Crozier et al. 2005). Resistance exercise and 
amino acid administration affects muscle protein synthesis 
additively and BCAA administration increases the aug-
mented phosphorylation of p70S6K1 by resistance exercise 
(Borgenvik et al. 2012). Therefore, different mechanisms 
between exercise and amino acids are proposed for stim-
ulating the mTOR pathway. However, in Crozier’s study 
(Crozier et al. 2005), administration of 0.135 or 0.337 g/kg 
BW leucine increased the phosphorylation of p70S6K1 
by four or six times its level in the control group, respec-
tively; furthermore, skeletal muscle protein synthesis rates 
were not different between the groups. This suggests that, 
in the present study, the difference that we observed in the 
phosphorylation of p706SK1 between the EC-Con and EC-
AminoL40 groups might not be large enough to be physi-
ologically important. Skeletal muscle protein synthesis 
was higher in the EC-AminoL40 group than in the EC-Con 
group, but was not different from the Sed group. This indi-
cates that the LEAA administration could partly improve 
the negative effect of EC on skeletal muscle protein syn-
thesis, but the factors which suppress the muscle protein 
synthesis still remained. In this study, we did not include 
a group that received LEAA without EC because our focus 
was on investigating the effect of LEAAs on skeletal mus-
cle protein synthesis rates after EC. Further studies are 
required to clarify the underlying discrepancy between pro-
tein synthesis and signaling.
In the current study, skeletal muscle protein synthesis 
and p70S6K1 phosphorylation were measured 50 min after 
administration of LEAAs or 60 min after ECs. Amino acid 
concentrations were elevated immediately, reached a peak 
Fig. 5  Effect of AminoL40 administration on mechanical paw with-
drawal threshold after EC. The mechanical withdrawal threshold in 
the EC-AminoL40 group was significantly higher than in the EC-Con 
group on days 1 and 2. Values are shown as mean ± SE (EC-Con and 
EC-AminoL40 groups, n = 11 for each group). *p < 0.05 compared 
with the EC-Con group
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at 30–60 min, and returned to basal levels approximately 
240 min after LEAAs administration. Furthermore, Katta et 
al. (2009) reported that the phosphorylation of p70S6K1 
was increased 0 and 1 h after ECs in rats. Thus, measure-
ment at 50 min post-administration of LEAAs, 60 min 
post-ECs allowed us to detect the peak change in skeletal 
muscle protein synthesis and p70S6K1 phosphorylation 
induced by the combination of LEAA administration and 
ECs.
We found that LEAA administration increased plasma 
insulin concentrations in plasma (Fig. 3). Insulin is a pow-
erful stimulator of protein synthesis, and leucine is known 
to stimulate insulin secretion. However, previous studies 
have reported that the stimulatory effect of leucine on mus-
cle protein synthesis occurs without a concomitant increase 
in serum insulin concentrations (Anthony et al. 2000). 
Furthermore, a previous study demonstrated that contrac-
tile activity is a potent stimulus for blunting the net pro-
tein synthesis rate in rat skeletal muscle ex vivo and can 
even override the anabolic effect of insulin (Miranda et al. 
2008). In our study, there was no correlation between insu-
lin concentrations and muscle protein synthesis (Fig. 4). 
Therefore, an increase in insulin concentration might not 
have contributed to the alleviation of reduction in muscle 
protein synthesis seen in our study.
We found that LEAA suppressed muscle soreness after 
EC (Fig. 5). This is the first study to investigate the effect of 
amino acids on muscle soreness after EC in rats. Although 
muscle soreness is a typical consequence of eccentric 
exercise-induced muscle damage, the underlying mecha-
nisms of muscle soreness are not clearly understood, but 
are probably related to the inflammatory response to mus-
cle damage (Cheung et al. 2003). Ge et al. (2009) reported 
that the muscle regeneration process is regulated by the 
mTOR pathway. Therefore, we investigated the effect of 
LEAAs, as a potent mTOR stimulator, on muscle sore-
ness. EC increased the phosphorylation of p70S6K1, and 
the combination of EC and LEAA administration increased 
the phosphorylation of p70S6K1 more than EC alone. The 
precise mechanisms by which LEAAs act to cause such 
effects remain to be determined, but LEAAs may allevi-
ate muscle soreness, an index of muscle damage, partly via 
activation of the mTOR pathway. BCAAs can be transami-
nated to glutamate to synthesize glutamine, which is highly 
consumed by inflammatory cells under inflammatory con-
ditions (Nicastro et al. 2012). Furthermore, BCAAs play 
a role as a precursor of glutamine and are metabolized to 
glutamine in skeletal muscle (Rennie and Tipton 2000). 
Therefore, BCAAs may affect the inflammatory status of 
damaged muscle by increased availability of amino acids as 
substrates for immune cells. Future studies should further 
investigate the molecular mechanisms mediated by LEAAs 
in the inflammatory process.
Pereira et al. reported that leucine administration 
improves the recovery of myofiber size and strength after 
cryolesion-induced muscle damage (Pereira et al. 2014). 
The dose of administered leucine in our study (0.4 g/kg 
body weight twice, for a total dose of 0.8 g/kg body weight) 
was less than the dose of 1.35 g/kg body weight/day used 
in the study conducted by Pereira et al. (2014). However, 
in the current study, plasma BCAA concentrations in the 
EC-AminoL40 group were increased by 4–10 times com-
pared with the EC-con group (Table 1). The increase in 
BCAA concentrations in plasma was sufficient to activate 
the mTOR pathway (Crozier et al. 2005). In the current 
study, LEAAs stimulated the phosphorylation of p70S6K1 
augmented by ECs. However, in a study conducted by 
Pereira et al. (2014), these beneficial effects of leucine 
were not associated with activation of the mTOR pathway 
in regenerating muscle. This difference between studies in 
intracellular signaling pathways remains unknown, but it 
could be because of the difference in the degree of mus-
cle damage. Muscle damage was not recovered until post-
cryolesion day 10 in the study conducted by Pereira et al. 
(2014). However, in our study, DOMS was recovered at 
3 days after EC. Therefore, the degree of muscle damage 
might be more moderate in this exercise-induced muscle 
damage model than in the cryolesion model. In moderately 
damaged muscle, protein synthesis may be more essential 
for regeneration than in the greatly damaged muscle. In the 
current study, muscle damage and muscle function were 
not specifically investigated because the blood sampling 
and tests required to assess the muscle function could have 
altered the results of the pain test.
Some reports have shown that administration of amino 
acid, particularly BCAA, administration suppresses DOMS 
1 day after exercise in humans (Jackman et al. 2010; Kirby 
et al. 2012; Nosaka et al. 2006). However, the mechanism 
by which leucine or BCAAs act to reduce the degree of 
muscle damage and the optimal composition to reduce the 
muscle soreness, remain unclear. We found that LEAAs 
alleviated muscle soreness after eccentric exercise in a rat 
model. Further studies using this animal model could help 
to address the questions of underlying mechanisms of leu-
cine/BCAA effects, optimal timing of administration, and 
optimal composition of amino acids. In a previous study 
(Murase et al. 2010), the paw withdrawal threshold was 
decreased 1, 2, and 3 days after EC, which is similar to 
the change in paw withdrawal observed in this study. Fur-
thermore, the B2 bradykinin receptor antagonist, HOE 140 
completely suppressed the muscle soreness when injected 
before EC, but when injected after EC failed to reverse 
muscle soreness that had already developed. In the current 
study, the LEAAs were administered 30 min before and 
10 min after EC. It remains unclear which of these admin-
istrations most affected the results. Further studies in this 
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animal model are needed to investigate the timing of LEAA 
administration. We also found that LEAAs alleviated the 
reduction in muscle protein synthesis, which led to a posi-
tive net balance of skeletal muscle protein turnover. These 
results suggest that the administration of LEAAs may 
enhance recovery from muscle damage induced by EC. 
Further studies are required to determine the mechanisms 
responsible for the effects of BCAA or LEAA supplemen-
tation on DOMS and to investigate whether the specific 
composition amino acid supplementations changes these 
effects.
In our study, we examined LEAAs, not leucine alone or 
BCAAs. Administration of leucine alone or BCAAs leads 
to a decrease in plasma concentrations of other essential 
amino acids in neonatal pigs (Escobar et al. 2005) and in 
humans (Borgenvik et al. 2012). In normal swine, reduced 
availability of amino acids leads to blunted muscle pro-
tein synthesis and amino acid supplementation recovers 
this reduced muscle protein synthesis (Kobayashi et al. 
2003). Furthermore, insulin-mediated hypoaminoacidemia 
reduces protein synthesis, and increased availability of all 
amino acids, but not leucine alone, recovers this reduction 
in protein synthesis. Therefore, other essential amino acids, 
except for BCAAs and leucine, may be essential for sus-
taining augmented muscle protein synthesis. Accordingly, 
LEAAs have been investigated to stimulate muscle pro-
tein synthesis after several types of exercise (Dreyer et al. 
2008; Pasiakos et al. 2011). Additionally, in our study, we 
found that LEAAs alleviated muscle damage after eccentric 
exercise. Therefore, LEAAs are effective for recovery after 
exercise via alleviation of muscle damage and enhance-
ment of muscle adaptation.
In conclusion, LEAAs suppress the decrease in mechan-
ical paw withdrawal threshold induced by EC in rats. 
Additionally, LEAAs alleviate impaired muscle protein 
synthesis by EC and further increases phosphorylation of 
p70S6K1 by EC. However, the precise mechanisms by 
which LEAAs act to confer such effects still need to be 
clarified. These findings suggest that LEAA administra-
tion before and after eccentric exercise hastens the recov-
ery from muscle soreness. Further studies are required to 
uncover novel mechanisms through which amino acids 
modulate muscle soreness and to determine whether long-
term treatment with LEAAs can effectively increase mus-
cle mass and improve muscle function.
Acknowledgments We thank Dr. Kazue Mizumura and Dr. Toru 
Taguchi for helpful advice on this animal model for assessing exer-
cise-induced muscle soreness, Dr. Makoto Bannai for valuable com-
ments on this paper, Dr. Hitoshi Murakami for critical reading and 
encouragement, Sachiko Yoshimoto, Kazuki Nishimura, and Yuki Shi-
bata for their assistance with the experimental trial.
Conflict of interest The authors declare that they have no conflict.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution License which permits any use, distribu-
tion, and reproduction in any medium, provided the original author(s) 
and the source are credited.
References
Anthony JC, Anthony TG, Layman DK (1999) Leucine supplementa-
tion enhances skeletal muscle recovery in rats following exercise. 
J Nutr 129:1102–1106
Anthony JC, Anthony TG, Kimball SR, Vary TC, Jefferson LS (2000) 
Orally administered leucine stimulates protein synthesis in skel-
etal muscle of postabsorptive rats in association with increased 
eIF4F formation. J Nutr 130:139–145
Biolo G, Tipton KD, Klein S, Wolfe RR (1997) An abundant supply 
of amino acids enhances the metabolic effect of exercise on mus-
cle protein. Am J Physiol 273:E122–E129
Borgenvik M, Apro W, Blomstrand E (2012) Intake of branched-
chain amino acids influences the levels of MAFbx mRNA and 
MuRF-1 total protein in resting and exercising human muscle. 
Am J Physiol Endocrinol Metab 302:E510–E521. doi:10.1152/
ajpendo.00353.2011
Calder AG, Anderson SE, Grant I, McNurlan MA, Garlick PJ (1992) 
The determination of low d5-phenylalanine enrichment (0.002–
0.09 atom percent excess), after conversion to phenylethylamine, 
in relation to protein turnover studies by gas chromatography/
electron ionization mass spectrometry. Rapid Commun Mass 
Spectrom 6:421–424
Charge SB, Rudnicki MA (2004) Cellular and molecular regulation 
of muscle regeneration. Physiol Rev 84:209–238. doi:10.1152/
physrev.00019.2003
Cheung K, Hume P, Maxwell L (2003) Delayed onset muscle sore-
ness: treatment strategies and performance factors. Sports Med 
33:145–164
Cleak MJ, Eston RG (1992) Delayed onset muscle soreness: mecha-
nisms and management. J Sports Sci 10:325–341
Crozier SJ, Kimball SR, Emmert SW, Anthony JC, Jefferson LS 
(2005) Oral leucine administration stimulates protein synthesis in 
rat skeletal muscle. J Nutr 135:376–382
Dreyer HC, Fujita S, Cadenas JG, Chinkes DL, Volpi E, Rasmussen 
BB (2006) Resistance exercise increases AMPK activity and 
reduces 4E-BP1 phosphorylation and protein synthesis in human 
skeletal muscle. J Physiol 576:613–624
Dreyer HC et al (2008) Leucine-enriched essential amino acid and 
carbohydrate ingestion following resistance exercise enhances 
mTOR signaling and protein synthesis in human muscle. Am J 
Physiol Endocrinol Metab 294:E392–E400
Escobar J, Frank JW, Suryawan A, Nguyen HV, Kimball SR, Jeffer-
son LS, Davis TA (2005) Physiological rise in plasma leucine 
stimulates muscle protein synthesis in neonatal pigs by enhancing 
translation initiation factor activation. Am J Physiol Endocrinol 
Metab 288:E914–E921. doi:10.1152/ajpendo.00510.2004
Garlick PJ, McNurlan MA (1998) Measurement of protein synthesis 
in human tissues by the flooding method. Curr Opin Clin Nutr 
Metab Care 1:455–460
Ge Y et al (2009) mTOR regulates skeletal muscle regeneration 
in vivo through kinase-dependent and kinase-independent 
mechanisms. Am J Physiol Cell Physiol 297:C1434–C1444. 
doi:10.1152/ajpcell.00248.2009
Gulbin JP, Gaffney PT (2002) Identical twins are discordant for mark-
ers of eccentric exercise-induced muscle damage. Int J Sports 
Med 23:471–476. doi:10.1055/s-2002-35076
Higbie EJ, Cureton KJ, Warren GL 3rd, Prior BM (1996) Effects 
of concentric and eccentric training on muscle strength, 
1201Leucine-enriched essential amino acids attenuate muscle soreness
1 3
cross-sectional area, and neural activation. J Appl Physiol 
81:2173–2181
Inoki K, Zhu T, Guan KL (2003) TSC2 mediates cellular energy 
response to control cell growth and survival. Cell 115:577–590
Jackman SR, Witard OC, Jeukendrup AE, Tipton KD (2010) 
Branched-chain amino acid ingestion can ameliorate soreness 
from eccentric exercise. Med Sci Sports Exerc 42:962–970
Katta A, Karkala SK, Wu M, Meduru S, Desai DH, Rice KM, 
Blough ER (2009) Lean and obese Zucker rats exhibit different 
patterns of p70s6 kinase regulation in the tibialis anterior mus-
cle in response to high-force muscle contraction. Muscle Nerve 
39:503–511. doi:10.1002/mus.21255
Kirby TJ, Triplett NT, Haines TL, Skinner JW, Fairbrother KR, 
McBride JM (2012) Effect of leucine supplementation on indices 
of muscle damage following drop jumps and resistance exercise. 
Amino acids 42:1987–1996. doi:10.1007/s00726-011-0928-9
Kobayashi H et al (2003) Reduced amino acid availability inhibits 
muscle protein synthesis and decreases activity of initiation fac-
tor eIF2B. Am J Physiol Endocrinol Metab 284:E488–E498. 
doi:10.1152/ajpendo.00094.2002
Miranda L, Horman S, De Potter I, Hue L, Jensen J, Rider MH (2008) 
Effects of contraction and insulin on protein synthesis, AMP-
activated protein kinase and phosphorylation state of transla-
tion factors in rat skeletal muscle. Pflugers Archiv Eur J Physiol 
455:1129–1140. doi:10.1007/s00424-007-0368-2
Murase S et al (2010) Bradykinin and nerve growth factor play piv-
otal roles in muscular mechanical hyperalgesia after exercise 
(delayed-onset muscle soreness). J Neurosci Off J Soc Neurosci 
30:3752–3761. doi:10.1523/JNEUROSCI.3803-09.2010
Nicastro H, da Luz CR, Chaves DF, Bechara LR, Voltarelli VA, Rog-
ero MM, Lancha AH Jr (2012) Does branched-chain amino acids 
supplementation modulate skeletal muscle remodeling through 
inflammation modulation? Possible mechanisms of action. J Nutr 
Metab 2012:136937. doi:10.1155/2012/136937
Nosaka K (2007) Muscle damage and amino acid supplementa-
tion: does it aid recovery from muscle damage? Int Sport Med J 
8:54–67
Nosaka K, Sacco P, Mawatari K (2006) Effects of amino acid supple-
mentation on muscle soreness and damage. Int J Sport Nutr Exerc 
Metab 16:620–635
Pasiakos SM et al (2011) Leucine-enriched essential amino acid sup-
plementation during moderate steady state exercise enhances pos-
texercise muscle protein synthesis. Am J Clin Nutr 94:809–818
Pereira MG, Baptista IL, Carlassara EO, Moriscot AS, Aoki MS, 
Miyabara EH (2014) Leucine supplementation improves skeletal 
muscle regeneration after cryolesion in rats. PLoS One 9:e85283. 
doi:10.1371/journal.pone.0085283
Proske U, Morgan DL (2001) Muscle damage from eccentric exer-
cise: mechanism, mechanical signs, adaptation and clinical appli-
cations. J Physiol 537:333–345
Rennie MJ, Tipton KD (2000) Protein and amino acid metabolism 
during and after exercise and the effects of nutrition. Annu Rev 
Nutr 20:457–483. doi:10.1146/annurev.nutr.20.1.457
Taguchi T, Matsuda T, Tamura R, Sato J, Mizumura K (2005) Muscu-
lar mechanical hyperalgesia revealed by behavioural pain test and 
c-Fos expression in the spinal dorsal horn after eccentric contrac-
tion in rats. J Physiol 564:259–268
Tesch PA (1988) Skeletal muscle adaptations consequent to long-term 
heavy resistance exercise. Med Sci Sports Exerc 20:S132–S134
Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR 
(2003) Essential amino acids are primarily responsible for the 
amino acid stimulation of muscle protein anabolism in healthy 
elderly adults. Am J Clin Nutr 78:250–258
